Real-time enrollment status for this diabetic macular edema clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:40 AM UTC
| NCT Number | NCT07449923 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Macular Edema |
| Phase | Clinical Trial |
| Target Enrollment | 240 participants |
| Active Locations | 50 sites in the US |
| Sponsor | EyePoint Pharmaceuticals, Inc. |
| Last Updated on CT.gov | July 6, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT07449923 is currently recruiting participants. This clinical trial study for diabetic macular edema is actively seeking new participants at 50 locations across the United States. The study is sponsored by EyePoint Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07449923 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07449923 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.